Company Overview and News

 
China’s Communists Rewrite the Rules for Foreign Businesses - The New York Times

2018-04-14 nytimes
The party is strengthening its influence — often gaining direct decision-making power — over the international firms doing business in China.

 
China rail offers ‘value and safety’

2018-01-21 thestar.com.my
CHINA Railway Group Ltd, a member of the Chinese consortium bidding for the Kuala Lumpur-Singapore High Speed Rail (HSR), is confident the consortium can emerge winner as “it can provide the best cost-performance value among the bidders”.

1
China, Hong Kong shares keep climbing; developers lend support

2018-01-05 thehindubusinessline
China and Hong Kong stocks extended their New Year rally on Friday, underpinned by robust gains in real estate firms. At 04:02 GMT, the Shanghai Composite index was up 7.95 points or 0.23 per cent at 3,393.66. China's blue-chip CSI300 index was up 0.24 per cent, with its financial sector sub-index higher by 0.61 per cent, the consumer staples sector down 0.4 per cent , the real estate index up 4.77 per cent and healthcare sub-index up 0.

 
Conference set to draw more business from China

2017-11-02 thestar.com.my
Organising committee: (standing, from left) MCCC honorary adviser Ng Lip Yong, honorary president Tan Sri Lim Gait Tong, president Tan Yew Sing, Chong and MCCC vice-president and Malaysia-China Entrepreneur Award organising chairman Ngan Teng Ye at the briefing

 
The Sinocism China Newsletter

2017-10-16 nb.sinocism
Happy Mid-Autumn Festival. China is on holiday until October 9 so the newsletter is very sporadic this week. There may be one more issue by the end of the weekend, then back to normal publishing next week.

 
The Sinocism China Newsletter

2017-10-13 nb.sinocism
Happy Wednesday…A bit under the weather here in DC, pardon any typos. If you are in Beijing have fun with the evening rush hour over the next few days. The city is warning that they will be epic…

 
19th Party Prep; North Korea's "Rocket Man"; Beijing Fighting Winter Smog; Tibetan Mastiff Oversupply--Sinocism-09.18.17 | Sinocism China Newsletter

2017-09-18 sinocism
Good Monday morning from swampy DC…today’s issue light on commentary, not feeling I have much to add today and figure sometimes less is more. I am testing another logo idea, honest comments always appreciated. Thanks for reading.

 
A Basket Of Stocks To Play The Impending Energy/EV Boom - Part 1 (Lithium)

2017-07-20 seekingalpha
The clean energy/electric vehicle space is starting to heat up and lithium is one commodity that stands to benefit greatly from this upcoming paradigm shift in technology and transportation.

 
'Extreme volatility' awaits iron ore, says Iron Road's Andrew Stocks

2017-07-05 theage.com.au
Iron ore markets are heading for a very bumpy ride in the next couple of years, marked by significant price swings amid the restructuring of the steel industry in China, according to the developer of a planned $US3.7 billion mine in Australia.

 
'Extreme volatility' awaits iron ore, says Iron Road's Andrew Stocks

2017-07-05 smh.com.au
Iron ore markets are heading for a very bumpy ride in the next couple of years, marked by significant price swings amid the restructuring of the steel industry in China, according to the developer of a planned $US3.7 billion mine in Australia.

 
Volatility to rule iron ore market for years given changes in steel industry in China: industry official

2017-07-05 scmp
Iron ore markets are heading for a very bumpy ride in the next couple of years, marked by significant price swings amid the restructuring of the steel industry in China, according to the developer of a planned US$3.7 billion mine in Australia.

 
What’s the Reason behind the Growth Explosion of Green Bonds?

2017-05-31 marketrealist
KEMMERER: This market is certainly an area of growing investor interest. Can you explain how green bonds are evaluated and what standards are used?

 
The hammer and sickle are making their way into some Hong Kong public companies

2017-05-30 scmp
As many as 19 Chinese state companies listed on the Hong Kong Stock Exchange have established Communist Party committees. Whose rules do they hew to?

 
Duterte to meet with 5 Chinese companies in Beijing

2017-05-14 globalnation.inquirer.net
In this Oct. 20, 2016 file photo, Philippine President Rodrigo Duterte (L) and his Chinese counterpart Xi Jinping shake hands after the signing of an agreement during Duterte’s state visit to China. AFP FILE PHOTO / POOL

 
Breakfast briefing: Friday, May 5

2017-05-05 thestar.com.my
MarketWrap: Wall Street ended flat on Thursday as a steep fall for the energy sector countered some solid earnings reports, with major stock indexes closing little changed after the US House of Representatives passed a healthcare overhaul. The DJIA fell 6.43 points, or 0.03%, to 20,951.47, the S&P 500 gained 1.39 points, or 0.06%, to 2,389.52 and the Nasdaq added 2.79 points, or 0.05%, to 6,075.34.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...